highlights

Active pharmaceutical ingredients from Singapore: what changes for the EU?

The EU recognises the equivalence of Singapore’s regulatory oversight system for APIs. Its inclusion on the list of recognised countries simplifies import documentation requirements, while GMP compliance and supplier qualification obligations remain in place.

New standards for alternative methods

The European Pharmacopoeia has revised its guidance on alternative microbiological methods, introducing clearer provisions for validation and implementation. The recent EDQM symposium in Strasbourg provides an opportunity to examine the implications for pharmaceutical quality control laboratories.

Many drugs, one factory

Business

A novelty in the world of biomaterials

A novelty in the world of biomaterials

Genitourinary Tumor Study ongoing with Active Screening and Enrollment

Genenta announces Long-Term follow-up observations in brain tumor (GBM) study with emerging survival signals

MAGAZINE

MakingPharmaIndustry | Issue 5_2026 | Speciale CPHI 2026

Special issue of MakingPharmaIndustry Magazine, published for CPHI 2026, the leading event for the pharmaceutical industry.

MakingPharmaIndustry | Issue 3_2026 | CPHI Special

The October issue of the MakingPharmaIndustry tabloid accompanies CPHI Milan 2026, exploring ATMPs, biotech, manufacturing, analytics, engineering and the technologies transforming the pharmaceutical industry.
spot_img
spot_img
spot_img
spot_img
spot_img